Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000676876 | SCV002028684 | uncertain significance | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; Alters the Kozak sequence, which plays a major role in the initiation of translation |
Athena Diagnostics | RCV000676876 | SCV005620657 | uncertain significance | not provided | 2024-09-30 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000676876 | SCV000802690 | likely benign | not provided | 2016-02-29 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003938030 | SCV004754483 | likely benign | SUCLA2-related disorder | 2020-02-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |